These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7113604)

  • 1. The incidence and pathogenesis of hyperlipidaemia in 16 consecutive acromegalic patients.
    Takeda R; Tatami R; Ueda K; Sagara H; Nakabayashi H; Mabuchi H
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):358-62. PubMed ID: 7113604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary type V hyperlipoproteinemia in an acromegalic patient without overt diabetes.
    Takeda R; Tatami R; Ueda K; Haba T; Kawato M; Nakabayashi H; Mabuchi H
    Endokrinologie; 1982 Feb; 79(1):140-8. PubMed ID: 7084127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipids in acromegaly.
    Nikkilä EA; Pelkonen R
    Metabolism; 1975 Jul; 24(7):829-38. PubMed ID: 1138157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA; Ylikahri R; Huttunen JK
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlipidaemia in renal transplant patients.
    Goldberg RB; Judelman JJ; Mindel A; Meyers AM; Salant DJ; Myburgh JA; Rabkin R; Joffe BI; Seftel HC
    S Afr Med J; 1976 Jul; 50(33):1291-4. PubMed ID: 785623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study in the pathogenesis of hyperlipemia in a patient with acromegaly and diabetes mellitus.
    Camitta FD; Gray TK
    Diabetes; 1969 Jan; 18(1):44-50. PubMed ID: 5761868
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum remnant lipoprotein cholesterol/triglyceride ratio as an index for screening familial type III hyperlipidaemia.
    Nakajima K; Daimon M; Kamiyama K; Takanashi K; Suzuki Y; Watanabe M; Kubono K; Saniabadi AR; Takashima S; Sakurabayashi I
    Ann Clin Biochem; 2007 Jul; 44(Pt 4):353-9. PubMed ID: 17663088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of atorvastatin on serum lipoproteins in acromegaly.
    Mishra M; Durrington P; Mackness M; Siddals KW; Kaushal K; Davies R; Gibson M; Ray DW
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):650-5. PubMed ID: 15943824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of hyperlipidemia in acromegaly.
    Aloia JF; Roginsky MS; Field RA
    J Clin Endocrinol Metab; 1972 Dec; 35(6):921-3. PubMed ID: 4634491
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raised erythrocyte sedimentation rate in asymptomatic hyperlipidaemia.
    Böttiger LE; Carlson LA; Ekelund LG; Olsson AG
    Br Med J; 1973 Jun; 2(5868):681-4. PubMed ID: 4733247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the nature and causes of hyperlipidaemia in uraemia, maintenance dialysis and renal transplantation.
    Ibels LS; Simons LA; King JO; Williams PF; Neale FC; Stewart JH
    Q J Med; 1975 Oct; 44(176):601-14. PubMed ID: 1105647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine levels in acromegaly patients.
    Hekimsoy Z; Ozmen B; Ulusoy S
    Neuro Endocrinol Lett; 2005 Dec; 26(6):811-4. PubMed ID: 16380700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipid metabolism in acromegaly].
    Ovcharova N
    Vutr Boles; 1977; 16(6):1-8. PubMed ID: 341530
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant.
    Sesmilo G; Fairfield WP; Katznelson L; Pulaski K; Freda PU; Bonert V; Dimaraki E; Stavrou S; Vance ML; Hayden D; Klibanski A
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1692-9. PubMed ID: 11932303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of octreotide on lipid metabolism in acromegaly.
    Cohen R; Chanson P; Bruckert E; Timsit J; Legrand A; Harris AG; Guillausseau PJ; Warnet A; Lubetzki J
    Horm Metab Res; 1992 Aug; 24(8):397-400. PubMed ID: 1526629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and insulin secretion in non-diabetic acromegalic patients.
    Coculescu M; Niculescu D; Lichiardopol R; Purice M
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):308-16. PubMed ID: 17516294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperlipoproteinaemia in primary gout: hyperlipoproteinaemic phenotype and influence of alcohol intake and obesity in Japan.
    Jiao S; Kameda K; Matsuzawa Y; Tarui S
    Ann Rheum Dis; 1986 Apr; 45(4):308-13. PubMed ID: 3707219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum ghrelin levels and disturbances of the lipid profile in patients with acromegaly.
    Jaskula M; Wasko R; Komarowska H; Dziubandowska A; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):245-55. PubMed ID: 19675514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test.
    Mazziotti G; Bonadonna S; Doga M; Patelli I; Gazzaruso C; Solerte SB; De Menis E; Giustina A
    Neuroendocrinology; 2008; 88(4):299-304. PubMed ID: 18617732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.